Isatuximab plus carfilzomib and dexamethasone in Japanese patients with relapsed multiple myeloma: subgroup analysis of the randomized, open label, phase 3 IKEMA study

Saved in:
Bibliographic Details
Published inJapanese journal of clinical oncology Vol. 52; no. 12; pp. 1446 - 1449
Main Authors Ishida, Tadao, Ito, Shigeki, Tanaka, Junji, Uchiyama, Michihiro, Kawano, Yawara, Moreau, Philippe, Martin, Thomas, Risse, Marie-Laure, Tada, Keisuke, Suzuki, Kenshi, Ishizawa, Kenichi
Format Journal Article
LanguageEnglish
Published England Oxford University Press 05.12.2022
Subjects
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Dexamethasone - therapeutic use
Humans
Japan
Letter
Multiple Myeloma - drug therapy
Japan
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:1465-3621
0368-2811
1465-3621
DOI:10.1093/jjco/hyac137